Mark Walshauser

Hematologist/Oncologist @cancercareIL • Medical Director St Elizabeth's Hospital • Member @asco @ash_hematology • Heartland NCORP Investigator

[OncoDaily @oncodaily]

🏆Celebrating New Recipients of the Fellow of ASCO🏆

Nilofer Azad @MGMcNamara @GIcancerDoc @thenasheffect @crisbergerot @DCarrizosaMD Moshe Chasky, Megan Daly @FunchainMD @JhanelleGray Jimmy J. Hwang @dotchillo @AMalone2012 @Oncn @Betzabe100 @BryanPSchneider @MikkaelSekeres @GevTamamyan @s_sivendran @walshauserMD @DrDWaterhouse @ASCO

https://t.co/s4K0chvpzZ

#Cancer #Oncology #OncoDaily #Health #FASCO #Medicine @CancerWorldmag

[Mark Walshauser @walshauserMD]

Thanks @ASCO, happy to join the FASCO club!
# FASCO #asco

[ASCO @ASCO]

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.

Learn more about FASCO distinction: https://t.co/z7oepv4s6G

[Mark Walshauser @walshauserMD]

Our @SWOG study just published in #JITC.

#immunotherapy #raretumors #DART @ASCO

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort https://t.co/NhXZWI0fye
@youngkwangchae @anup_kasi @walshauserMD @EdgarEGK @Dra_Cells @EladSharonMD @cara_haymaker @Dr_R_Kurzrock

[Vincent Rajkumar @VincentRK]

China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. @IQVIA_global

https://t.co/hTOHIDdyo6

[Mark Walshauser @walshauserMD]

This👇🏼👇🏼

[ASCO @ASCO]

ASCO is calling on lawmakers to uphold the U.S.’s role as a global leader in scientific and medical innovation and preserve vital federal cancer prevention and research funding. #ASCOAdvocacy

Read our statement: https://t.co/6txS0eCFBd

[Mark Walshauser @walshauserMD]

Thanks @RepBobOnder for rushing back from the floor to meet with us and @ASCO at the 2025 #ASCOAdvocacySummit to:  

➡️Prioritize federal research funding
➡️#FixPriorAuth
➡️Help end #drugshortages

[Mark Walshauser @walshauserMD]

Thank you so much — representative Brian Fitzpatrick from the great state of Pennsylvania — for improving your constituents access to cancer care @RepBrianFitz @ASCO #ASCOAdvocacySummit

[Mark Walshauser @walshauserMD]

I am honored to be named an Advocacy Champion by @ASCO at the #ASCOAdvocacySummit! Committed to advocate for policies that expand timely access to #cancer care and #clinicaltrials, especially for our vulnerable older adults. Together, we can make a difference! 🎗️

[Jasmine Kamboj, MD, FASCO @JasmineKambojMD]

What an evening at the #AscoAdvocacySummit
Thank you @herbconaway @RepJohnJoyce for sharing your thoughts,
Advocacy priorities this year:-
✅support cancer research funding
✅end drug shortages
✅cosponsor Seniors Timely Access to Care Act/ reform prior auth.
Thanks to all the @ASCO Advocacy Champions, your efforts and dedication are needed more than ever.
@epbalaban @RayPageDOPhD @montypal @AshleySumrallMD @walshauserMD @ASCOPres @EricBernicker @fumikochino @DrSGraff @DrBonillaOnc @BarbaraMcAneny @KurtOettelMD @WadeSwenson @IshwariaMD @Lymphoma_Doc @neerajaiims @DevikaDasMD @SameerKeoleMD @MiriamKnoll @RManochakian and so many more 🎀🥳

[OncoDaily @oncodaily]

Empowering Oncologists | How do I do research and leadership while pursuing partnership track?
@JasmineKambojMD @walshauserMD

https://t.co/uYGwSm2ULh

#Cancer #EmpoweringOncologists #OncoDaily #Oncology #Medicine #Health #MedEd #MedX #MedNews

[Mark Walshauser @walshauserMD]

Great conversation with @JasmineKambojMD on @oncodaily talking about
✅ Private practice
✅APP’s in practice
✅ Navigating clinical duties while advancing in leadership and research
#oncology #hematology #privatepractice

[OncoDaily @oncodaily]

Episode 3 of Empowering Oncologists: Dr. Jasmine Kamboj sits down with Dr. Mark Walshauser to tackle a question many oncologists face: How do I balance research and leadership while pursuing the partnership track? @JasmineKambojMD @WalshauserMD https://t.co/SMXbsHe3ks

[Mark Walshauser @walshauserMD]

Long $RIVN

[JoshWest247 ⚡️ @JoshWest247]

Absolutely INSANE lineups to get into Rivian!!! 🤯

[Mark Walshauser @walshauserMD]

I contacted my lawmakers about protecting patients' timely access to care. Join me! #ASCOAdvocacy https://t.co/BbJHrj1PPy @ASCO @HawleyMO @SenEricSchmitt #priorauth

[Alan Tan @alantanmd]

The Vanderbilt University Ingram Cancer Center Genitourinary team is expanding. We are seeking a GU medical oncology clinical investigator to join our innovative team. Please message me or @brian_rini to inquire further. We will also be at #ESMO24

[Ted Okon @TedOkonCOA]

This graph from @axios is as alarming as it gets. The top 6 for-profit insurers' revenue is almost 30% of US health spending. Think about that for a moment!

[Mark Walshauser @walshauserMD]

@JasmineKambojMD @ASCO Congrats!

[Yakup Ergün @dr_yakupergun]

#ASCO24

Treatment Selection and Sequencing in Breast Cancer👇

From the wonderful presentation by Dr. Ana Christina Garrido-Castro

@OncoAlert

[OncoDaily @oncodaily]

ASCO's President's Circle Advocates

@ASCO @ASCOPres

@DrDonaldHarvey, @MarilynHeineMD, @JasmineKambojMD, @AmandaNizamMD, @montypal, Banu Symington, @walshauserMD, Robin Zon

https://t.co/1hGeCsW93B

#oncodaily #oncology #cancer #ASCO #canceradvocacy #oncologyleadership #patientadvocacy #policyinfluence #cancerresearch #advocacyefforts

[Vincent Rajkumar @VincentRK]

10 suggested action items for physician colleagues suffering under the burden of @ABIMcert MOC. #MedTwitter

1. If your institution allows it, stop participating in MOC. Personally, MOC has no value to me.

[Mark Walshauser @walshauserMD]

Thank you @SenEricSchmitt for your strong support for @ASCO and our patients.
We are asking to:
1️⃣ End shortages of life saving drugs
2️⃣ Support @NIH, NCI, & @ARPA_H funding
3️⃣ Make telemedicine permanent
#ASCOAdvocacySummit